Dermapharm Holding Third Quarter 2024 Earnings: EPS: €0.60 (vs €0.46 in 3Q 2023)

By Yahoo! Finance | Nov 17, 2024 at 01:44 AM EST

The chart displays figures for the trailing 12 months. Revenue is expected to grow by 4.0% annually for the next 3 years, exceeding the Pharmaceuticals industry in Germany. However, 2 warning signs have been identified for Dermapharm Holding, highlighting potential investment risks.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.